Epoxidized linseed oil BioMed™ is a high‑purity, bio‑based plasticizer and stabilizer designed specifically for PVC medical products that require exceptional safety, biocompatibility, and environmental performance. Derived from renewable linseed oil through a precision epoxidation process and manufactured in China under strict quality control, epoxidized linseed oil BioMed™ offers excellent compatibility with medical‑grade PVC used in products such as infusion sets, transfusion tubing, IV and blood bags, catheters, breathing circuits, and soft connectors.
In PVC formulations, epoxidized linseed oil BioMed™ provides the necessary flexibility, clarity, and long‑term durability while maintaining a non‑toxic profile. Its very low migration and strong chemical stability greatly reduce the risk of harmful substances leaching out during contact with blood, infusion solutions, or body fluids. This is especially important for devices used in pediatrics and neonatal care, where infants and young children are particularly sensitive to traditional plasticizers. By replacing conventional petroleum‑based and phthalate plasticizers, epoxidized linseed oil BioMed™ helps minimize potential endocrine and developmental risks for children.
Epoxidized linseed oil BioMed™ is engineered to remain stable under common medical sterilization methods, including heat, ethylene oxide, and gamma irradiation. This stability prevents significant degradation of the PVC matrix and avoids the formation of unwanted by‑products, helping ensure consistent safety and performance throughout the product’s service life.
From an environmental perspective, the renewable origin of epoxidized linseed oil BioMed™ supports reduced dependence on fossil resources and can contribute to a lower carbon footprint for medical device manufacturers. By combining safety, sustainability, and process reliability, epoxidized linseed oil BioMed™ enables the production of PVC medical devices that are harmless to children, gentle to patients, and more friendly to the environment, meeting the rising expectations of hospitals, regulators, and global healthcare brands.